You are here: Home » News-CM » Companies » News
Business Standard

Dr. Reddy's Laboratories launches Lansoprazole Delayed-Release Capsules USP, 15 mg in US market

Capital Market 

Dr. Reddy's Laboratories announced the launch of Lansoprazole Delayed-Release Capsules USP, 15 mg, an over-the-counter (OTC) store-brand equivalent of Prevacid 24HR Capsules, in the United States market, as approved by the U. S.

Food and Drug Administration (USFDA).

Dr. Reddy's OTC Lansoprazole Delayed-Release Capsules USP, 15 mg, is an over-the-counter, Proton Pump Inhibitor (PPI) used to treat frequent heartburn occurring two or more days a week.

Dr. Reddy's OTC Lansoprazole Delayed-Release Capsules USP, 15 mg, are available in 14, 28 and 42 count sizes.

The Prevacid 24HR brand and generic had U. S. sales of approximately $57 million MAT for the most recent twelve months ending in August 2019 according to IRi

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, September 16 2019. 12:01 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU